Yao, Y., Yan, Y., Suman, V. J., Dietz, A. B., Erskine, C. L., Dimou, A., . . . Block, M. S. Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationYao, Yuan, et al. Phase I Study of Pembrolizumab in Combination with Ibrutinib for the Treatment of Unresectable or Metastatic Melanoma. Frontiers Media S.A.
MLA (9th ed.) CitationYao, Yuan, et al. Phase I Study of Pembrolizumab in Combination with Ibrutinib for the Treatment of Unresectable or Metastatic Melanoma. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.